v3.25.2
Related party transactions (Details) - CHF (SFr)
1 Months Ended 3 Months Ended 6 Months Ended 18 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Related party transactions            
Salaries, other short-term employee benefits and post-employment benefits   SFr 99,864 SFr 95,934 SFr 197,156 SFr 155,762  
Share-based compensation   18,910 46,368 43,428 98,766  
Key management compensation   118,774 142,302 240,584 254,528  
Fair value of Income recognised for services received at zero cost   34,505   105,560    
Fair value of services received at zero cost recorded as other operating cost   34,505   105,560    
Discontinued operations            
Related party transactions            
Salaries, other short-term employee benefits and post-employment benefits     345,177   664,525  
Share-based compensation     999,751   1,260,638  
Key management compensation     1,344,928   1,925,163  
Discontinued operations as disclosed below            
Related party transactions            
Key management compensation         1,900,000  
Net gain on Neurosterix Transaction   117,747 14,390,211 117,747 13,961,900 SFr 14,100,000
Executive Management | Discontinued operations as disclosed below            
Related party transactions            
Net payable     SFr 100,000   SFr 100,000  
Neurosterix Group            
Related party transactions            
Fair value of Income recognised for services received at zero cost   34,505   105,560    
Fair value of services received at zero cost recorded as other operating cost   34,505   105,560    
Neurosterix Pharma Sarl            
Related party transactions            
Net receivable SFr 60,074 SFr 60,074   SFr 60,074   SFr 60,074
Stalicla SA            
Related party transactions            
Investment in Stalicla SA SFr 795,029          
Preferred shares received on investment in Stalicla SA 23,342